Cardinal Health, Inc. (NYSE: CAH) Stock Competitors & Peer Comparison
See CAH's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CAH and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CAH | $232.16 | -0.55% | 54.4B | 22.25 | $10.43 | +0.89% |
| MCK | $910.33 | -1.23% | 106.6B | 22.30 | $40.82 | +0.37% |
| COR | $317.25 | +0.28% | 61.7B | 18.50 | $17.15 | +0.75% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $83.66 | -1.39% | 9.5B | 15.76 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| AHG | $1.21 | +3.42% | 1B | -5.67 | -$0.21 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| EMPG | $17.36 | +0.00% | 143M | 192.89 | $0.09 | N/A |
| HX | $2.24 | -4.27% | 53.4M | -1.84 | -$1.22 | N/A |
Stock Comparison
McKesson Corporation (NYSE: MCK)
CAH vs MCK Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, MCK has a market cap of 106.6B. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while MCK trades at $910.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas MCK's P/E ratio is 22.30. In terms of profitability, CAH's ROE is -0.60%, compared to MCK's ROE of -1.94%. Regarding short-term risk, CAH is less volatile compared to MCK. This indicates lower risk in terms of short-term price fluctuations for CAH.Check MCK's competition here
Cencora, Inc. (NYSE: COR)
CAH vs COR Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, COR has a market cap of 61.7B. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while COR trades at $317.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas COR's P/E ratio is 18.50. In terms of profitability, CAH's ROE is -0.60%, compared to COR's ROE of +1.06%. Regarding short-term risk, CAH is more volatile compared to COR. This indicates higher risk in terms of short-term price fluctuations for CAH.Check COR's competition here
AmerisourceBergen Corporation (NYSE: ABC)
CAH vs ABC Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas ABC's P/E ratio is 21.92. In terms of profitability, CAH's ROE is -0.60%, compared to ABC's ROE of +1.06%. Regarding short-term risk, CAH is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for CAH.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
CAH vs HSIC Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, HSIC has a market cap of 9.5B. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while HSIC trades at $83.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas HSIC's P/E ratio is 15.76. In terms of profitability, CAH's ROE is -0.60%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, CAH is less volatile compared to HSIC. This indicates lower risk in terms of short-term price fluctuations for CAH.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
CAH vs PDCO Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas PDCO's P/E ratio is 20.48. In terms of profitability, CAH's ROE is -0.60%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, CAH is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for CAH.Check PDCO's competition here
Akso Health Group (NASDAQ: AHG)
CAH vs AHG Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, AHG has a market cap of 1B. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while AHG trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas AHG's P/E ratio is -5.67. In terms of profitability, CAH's ROE is -0.60%, compared to AHG's ROE of -0.15%. Regarding short-term risk, CAH is less volatile compared to AHG. This indicates lower risk in terms of short-term price fluctuations for CAH.Check AHG's competition here
Owens & Minor, Inc. (NYSE: OMI)
CAH vs OMI Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas OMI's P/E ratio is -0.47. In terms of profitability, CAH's ROE is -0.60%, compared to OMI's ROE of +0.63%. Regarding short-term risk, CAH is less volatile compared to OMI. This indicates lower risk in terms of short-term price fluctuations for CAH.Check OMI's competition here
Empro Group Inc. Ordinary shares (NASDAQ: EMPG)
CAH vs EMPG Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, EMPG has a market cap of 143M. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while EMPG trades at $17.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas EMPG's P/E ratio is 192.89. In terms of profitability, CAH's ROE is -0.60%, compared to EMPG's ROE of +0.66%. Regarding short-term risk, CAH is more volatile compared to EMPG. This indicates higher risk in terms of short-term price fluctuations for CAH.Check EMPG's competition here
Akso Health Group (NASDAQ: HX)
CAH vs HX Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas HX's P/E ratio is -1.84. In terms of profitability, CAH's ROE is -0.60%, compared to HX's ROE of -1.07%. Regarding short-term risk, CAH is less volatile compared to HX. This indicates lower risk in terms of short-term price fluctuations for CAH.Check HX's competition here
Accendra Health, Inc. (NYSE: ACH)
CAH vs ACH Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, ACH has a market cap of 37M. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while ACH trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas ACH's P/E ratio is 0.71. In terms of profitability, CAH's ROE is -0.60%, compared to ACH's ROE of +0.63%. Regarding short-term risk, CAH is less volatile compared to ACH. This indicates lower risk in terms of short-term price fluctuations for CAH.Check ACH's competition here
111, Inc. (NASDAQ: YI)
CAH vs YI Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, YI has a market cap of 27.5M. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while YI trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas YI's P/E ratio is -1.90. In terms of profitability, CAH's ROE is -0.60%, compared to YI's ROE of +0.24%. Regarding short-term risk, CAH is less volatile compared to YI. This indicates lower risk in terms of short-term price fluctuations for CAH.Check YI's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
CAH vs WGRX Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas WGRX's P/E ratio is -0.33. In terms of profitability, CAH's ROE is -0.60%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, CAH is less volatile compared to WGRX. This indicates lower risk in terms of short-term price fluctuations for CAH.Check WGRX's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
CAH vs MEDS Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, MEDS has a market cap of 7.6M. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while MEDS trades at $2.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas MEDS's P/E ratio is N/A. In terms of profitability, CAH's ROE is -0.60%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, CAH is less volatile compared to MEDS. This indicates lower risk in terms of short-term price fluctuations for CAH.Check MEDS's competition here
Zynex, Inc. (NASDAQ: ZYXI)
CAH vs ZYXI Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, CAH's ROE is -0.60%, compared to ZYXI's ROE of +3.14%. Regarding short-term risk, CAH is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for CAH.Check ZYXI's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
CAH vs HKPD Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, HKPD has a market cap of 1.1M. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while HKPD trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas HKPD's P/E ratio is -1.48. In terms of profitability, CAH's ROE is -0.60%, compared to HKPD's ROE of -0.15%. Regarding short-term risk, CAH is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for CAH.Check HKPD's competition here
Synergy CHC Corp. (NASDAQ: SNYR)
CAH vs SNYR Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, SNYR has a market cap of 941.8K. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while SNYR trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas SNYR's P/E ratio is -0.06. In terms of profitability, CAH's ROE is -0.60%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, CAH is less volatile compared to SNYR. This indicates lower risk in terms of short-term price fluctuations for CAH.Check SNYR's competition here
Ridgetech, Inc. (NASDAQ: RDGT)
CAH vs RDGT Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, RDGT has a market cap of 880K. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while RDGT trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas RDGT's P/E ratio is -0.02. In terms of profitability, CAH's ROE is -0.60%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, CAH is less volatile compared to RDGT. This indicates lower risk in terms of short-term price fluctuations for CAH.Check RDGT's competition here
Covetrus, Inc. (NASDAQ: CVET)
CAH vs CVET Comparison October 2026
Cardinal Health, Inc. (NYSE: CAH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAH stands at 54.4B. In comparison, CVET has a market cap of 0. Regarding current trading prices, CAH is priced at $232.16 on the NYSE, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAH currently has a P/E ratio of 22.25, whereas CVET's P/E ratio is -69.97. In terms of profitability, CAH's ROE is -0.60%, compared to CVET's ROE of -0.06%. Regarding short-term risk, CAH is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for CAH.Check CVET's competition here